01.06.2013 | Letter to the Editor
Decrease in blood miR-296 predicts chemotherapy resistance and poor clinical outcome in patients receiving systemic chemotherapy for metastatic colon cancer
Erschienen in: International Journal of Colorectal Disease | Ausgabe 6/2013
Einloggen, um Zugang zu erhalten